|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004083,
umls-concept:C0032105,
umls-concept:C0041485,
umls-concept:C0078058,
umls-concept:C0080309,
umls-concept:C0138514,
umls-concept:C0155626,
umls-concept:C0286651,
umls-concept:C0442805,
umls-concept:C0547047,
umls-concept:C1171892,
umls-concept:C1749467
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2006-7-3
|
|
pubmed:abstractText |
This study examined whether atorvastatin increases plasma levels of soluble Fms-like tyrosine kinase 1 (sFlt-1) and reciprocally decreases vascular endothelial growth factor (VEGF) and placental growth factor (PlGF) levels in patients with acute myocardial infarction (AMI).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/FLT1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Growth Substances,
http://linkedlifedata.com/resource/pubmed/chemical/Heptanoic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA...,
http://linkedlifedata.com/resource/pubmed/chemical/Inflammation Mediators,
http://linkedlifedata.com/resource/pubmed/chemical/Pregnancy Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrroles,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor...,
http://linkedlifedata.com/resource/pubmed/chemical/atorvastatin,
http://linkedlifedata.com/resource/pubmed/chemical/placenta growth factor
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1558-3597
|
|
pubmed:author |
pubmed-author:FujiokaDaisukeD,
pubmed-author:KawabataKen-ichiK,
pubmed-author:KittaYoshinobuY,
pubmed-author:KobayashiTsuyoshiT,
pubmed-author:KodamaYasushiY,
pubmed-author:KugiyamaKiyotakaK,
pubmed-author:MendeAkiraA,
pubmed-author:NakamuraTakamitsuT,
pubmed-author:ObataJyun-eiJE,
pubmed-author:SaitoYukioY,
pubmed-author:TakanoHajimeH,
pubmed-author:UmetaniKenK
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
4
|
|
pubmed:volume |
48
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
43-50
|
|
pubmed:dateRevised |
2009-11-25
|
|
pubmed:meshHeading |
pubmed-meshheading:16814647-Double-Blind Method,
pubmed-meshheading:16814647-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:16814647-Female,
pubmed-meshheading:16814647-Growth Substances,
pubmed-meshheading:16814647-Heptanoic Acids,
pubmed-meshheading:16814647-Humans,
pubmed-meshheading:16814647-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:16814647-Inflammation Mediators,
pubmed-meshheading:16814647-Male,
pubmed-meshheading:16814647-Middle Aged,
pubmed-meshheading:16814647-Myocardial Infarction,
pubmed-meshheading:16814647-Pregnancy Proteins,
pubmed-meshheading:16814647-Pyrroles,
pubmed-meshheading:16814647-Stroke Volume,
pubmed-meshheading:16814647-Vascular Endothelial Growth Factor A,
pubmed-meshheading:16814647-Vascular Endothelial Growth Factor Receptor-1,
pubmed-meshheading:16814647-Ventricular Function, Left
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Atorvastatin increases plasma soluble Fms-like tyrosine kinase-1 and decreases vascular endothelial growth factor and placental growth factor in association with improvement of ventricular function in acute myocardial infarction.
|
|
pubmed:affiliation |
Department of Internal Medicine II, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, Nakakoma-gun, Yamanashi, Japan.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
